Hui Hu
Impact in
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
- Materials Chemistry top 10%
- Advanced Nanomaterials in Catalysis
- MXene and MAX Phase Materials
- Nanocluster Synthesis and Applications
Papers in ⓘ
-
- Extracellular vesicles in disease 5
- Angiogenesis and VEGF in Cancer 4
- Circular RNAs in diseases 3
- Oncology 7
- Co-authors
- Yu Chen (6 shared papers)Wei Feng (5 shared papers)Yuehua Li (4 shared papers)Xiaoqin Qian (4 shared papers)Luodan Yu (2 shared papers)Xiuguo Han (1 shared paper)Yuehua Li (1 shared paper)Huijing Xiang (1 shared paper)
- Journals
- Frontiers in Pediatrics (2 papers)Chemical Engineering Journal (2 papers)Nutrients (1 paper)Advanced Materials (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Hui Hu
32 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Biomedical Engineering 575
- Materials Chemistry 530
- Biomaterials 138
- Cancer Research 153
- Molecular Biology 502
Countries citing papers authored by Hui Hu
This map shows the geographic impact of Hui Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Hu more than expected).
Fields of papers citing papers by Hui Hu
This network shows the impact of papers produced by Hui Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Hu. The network helps show where Hui Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases Hit paper breakdown → | 2021 | 426 |
| 2 | 2021 | 213 | |
| 3 | 2020 | 110 | |
| 4 | 2016 | 81 | |
| 5 | 2019 | 73 | |
| 6 | 2022 | 72 | |
| 7 | 2022 | 51 | |
| 8 | 2019 | 50 | |
| 9 | 2021 | 32 | |
| 10 | 2018 | 28 | |
| 11 | 2019 | 26 | |
| 12 | Comparison of endothelial cell- and endothelial progenitor cell-derived exosomes in promoting vascular endothelial cell repair. | 2019 | 20 |
| 13 | 2018 | 12 | |
| 14 | 2022 | 11 | |
| 15 | 2021 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2024 | 8 | |
| 18 | 2020 | 7 | |
| 19 | 2020 | 6 | |
| 20 | 2022 | 5 |
About Hui Hu
Hui Hu is a scholar working on Molecular Biology, Oncology, Epidemiology, Cancer Research and Biomedical Engineering, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Extracellular vesicles in disease (5 papers), Angiogenesis and VEGF in Cancer (4 papers), Gastrointestinal motility and disorders (3 papers), Circular RNAs in diseases (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Advanced Nanomaterials in Catalysis (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Biomedical Engineering (575 citations), Materials Chemistry (530 citations), Biomaterials (138 citations), Cancer Research (153 citations) and Molecular Biology (502 citations). Hui Hu has collaborated with scholars based in China and United States. Frequent co-authors include Yu Chen, Wei Feng, Yuehua Li, Xiaoqin Qian, Luodan Yu, Xiuguo Han, Yuehua Li, Huijing Xiang, Li Ding and Meiqi Chang. Their work appears in journals such as Frontiers in Pediatrics, Chemical Engineering Journal, Nutrients, Advanced Materials and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.